Literature DB >> 17301647

Low prevalence of Helicobacter pylori infection in young children in the Netherlands.

Petronella E C Mourad-Baars1, Hein W Verspaget, Bart J A Mertens, M Luisa Mearin.   

Abstract

AIM OF THE STUDY: To investigate the seroprevalence of Helicobacter pylori infection in young children from the general population in The Netherlands.
METHODS: Determination of IgG antibodies against H. pylori, using an enzyme-linked immunosorbent assay technique [cutoff 0.32 Absorption Index (AI)], in serum from 1258 children who were 2-4 years of age. The serum was obtained from a serum bank of 6127 children who attended the community child healthcare centers in the Dutch province of Zuid-Holland.
RESULTS: In general, we found a seroprevalence of 1.2% of H. pylori infection, with a significant difference between the children with parents who were both Dutch (0.5%), and the children with at least one non-Dutch parent (2.6%) (P<0.001).
CONCLUSIONS: The prevalence of H. pylori infection in young infants in the general population in The Netherlands is low. Children with at least one non-Dutch parent form a risk group, however, for H. pylori infection in The Netherlands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301647     DOI: 10.1097/MEG.0b013e328011050f

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

Review 1.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

2.  Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood.

Authors:  Caroline M den Hoed; Anne J Vila; Ingrid L Holster; Guillermo I Perez-Perez; Martin J Blaser; Johan C de Jongste; Ernest J Kuipers
Journal:  Helicobacter       Date:  2011-10       Impact factor: 5.753

3.  H. pylori vaccines: why we still don't have any.

Authors:  Songhua Zhang; Leonard Moise; Steven F Moss
Journal:  Hum Vaccin       Date:  2011-11-01

Review 4.  Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia.

Authors:  T van den Bruele; P E C Mourad-Baars; E C J Claas; R N van der Plas; E J Kuijper; R G M Bredius
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-17       Impact factor: 3.267

5.  Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands.

Authors:  A C de Vries; G A Meijer; C W N Looman; M K Casparie; B E Hansen; N C T van Grieken; E J Kuipers
Journal:  Gut       Date:  2007-08-14       Impact factor: 23.059

6.  Helicobacter pylori Infection in Children: a Comprehensive Review.

Authors:  Sanaz Mehrabani
Journal:  Maedica (Buchar)       Date:  2019-09

7.  A combined antral and corpus rapid urease testing protocol can increase diagnostic accuracy despite a low prevalence of Helicobacter pylori infection in patients undergoing routine gastroscopy.

Authors:  Vikrant Parihar; Grainne Holleran; Barry Hall; Denise Brennan; Paul Crotty; Deirdre McNamara
Journal:  United European Gastroenterol J       Date:  2015-10       Impact factor: 4.623

8.  Positive association between Helicobacter pylori and gastroesophageal reflux disease in children.

Authors:  Aeri Moon; Aliza Solomon; Debra Beneck; Susanna Cunningham-Rundles
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-09       Impact factor: 2.839

9.  Helicobacter pylori infection in children.

Authors:  Shaman Rajindrajith; Niranga M Devanarayana; Hithanadura Janaka de Silva
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

10.  Deprivation, timing of preschool infections and H. pylori seropositivity at age 49-51 years: the Newcastle Thousand Families birth cohort.

Authors:  Mark S Pearce; David I Campbell; Kay D Mann; Louise Parker; Julian E Thomas
Journal:  BMC Infect Dis       Date:  2013-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.